FracturePhase 4NCT01544725
Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults
A Phase 4 study testing Procedural sedation with ketamine-propofol combination and Procedural sedation with ketamine alone in people with Fracture and Dislocation, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
Trial summary
Using Ketamine for procedural sedation in adults is often uncomfortable for emergency physicians because of the significant proportion of patients experimenting recovery agitation. The investigators believe that combining propofol to ketamine, the proportion of recovery agitation will be significantly lowered. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Fracture, Dislocation
- What is being tested?
- Procedural sedation with ketamine-propofol combination and Procedural sedation with ketamine alone
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 1 siteFrance
- Study dates
- Apr 2012to Jan 2016
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years and older
- indication of procedural sedation
Who cannot join
- allergy to propofol or ketamine
- alcohol or drug intoxication
- altered mental status
- ASA physical status score > 2
- hemodynamic unstability
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults : a Blinded, Randomized Controlled Trial
Using Ketamine for procedural sedation in adults is often uncomfortable for emergency physicians because of the significant proportion of patients experimenting recovery agitation. The investigators believe that combining propofol to ketamine, the proportion of recovery agitation will be significantly lowered.
The objectives of this double-blinded, randomized controlled trial are to compare the proportion of recovery agitation in adults receiving procedural sedation with ketamine-propofol versus ketamine alone, and to compare the proportion of other classical procedural sedation side-effects and parameters such as respiratory depression, hypotension, sedation duration, time of recovery, procedural failures, and levels of satisfaction.
- Conditions
- Fracture, Dislocation
- Being tested
- Procedural sedation with ketamine-propofol combination, Procedural sedation with ketamine alone
- Keywords
- Procedural sedation, Ketamine-propofol, Ketamine
- Medical subject headings
- Fractures, Bone, Joint Dislocations
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Procedural sedation with ketamine-propofol combinationDrug
K= Kétamine P= Propofol RSS= Ramsay Sedation Score
At t0: 0.5 mg/kg of K (0.1 ml/kg of 5 mg/ml K) followed by 0.5 mg/k of P (0.1 ml/kg of 5 mg/ml P).
At t0 + 4 min, if needed to obtain an optimal sedation (RSS of 4 or 5): 0.25 mg/kg of K (0.05 ml/kg of 5 mg/ml K) followed by 0.25 mg/kg of P (0.05 ml/kg of 5 mg/ml P).
At t0 + 8 min, if needed to obtain an optimal sedation (RSS of 4 or 5): 0.25 mg/kg of K (0.05 ml/kg of 5 mg/ml K) followed by 0.25 mg/kg of P (0.05 ml/kg of 5 mg/ml P).
At t0 + 12 min, if maximal doses have been reached (1 mg/kg of K + 1 mg/kg of P) but the optimal sedation has not been obtained, the procedural sedation will be recorded as a failure in the analysis, and the patient will receive another procedural sedation product (at the discretion of the caregiver).
Procedural sedation with ketamine aloneDrug
K= Ketamine I= Intralipid placebo
At t0: 1 mg/kg of K (0.1 ml/kg of 10 mg/ml K), followed by 0.1 ml/kg of I (physical placebo of propofol in the other arm).
At t0 + 4 min, if needed to obtain an optimal sedation (Ramsay Sedation Score of 4 or 5): 0.5 mg/kg of K (0.05 ml/kg of 10 mg/ml K), followed by 0.05 ml/kg of I.
At t0 + 8 min, if needed to obtain an optimal sedation (Ramsay Sedation Score of 4 or 5): 0.5 mg/kg of K (0.05 ml/kg of 10 mg/ml K), followed by 0.05 ml/kg of I.
At t0 + 12 min, if maximal doses have been used (2 mg/kg of K) but the optimal sedation has not been obtained, the procedural sedation will be recorded as a failure in the analysis, and the patient will receive another procedural sedation product (at the discretion of the caregiver).
| Study group | Role | What they receive |
|---|---|---|
| Ketamine-propofol | Experimental | Not described Receives: Drug: Procedural sedation with ketamine-propofol combination |
| Ketamine alone | Active comparator | Not described Receives: Drug: Procedural sedation with ketamine alone |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of recovery agitation
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
Measured: Recovery agitation is noted after procedural sedation for each patient (30 minutes)
Secondary outcomes (8)
Time from first injection to optimal sedation
Measured: Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection (30 minutes)
Proportion of respiratory depression
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
Measured: respiratory depression is assessed during procedural sedation for each patient (30 minutes)
Proportion of arterial hypotension
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
Measured: Hypotension is assessed during procedural sedation for each patient (30 minutes)
Proportion of vomiting
Patient will be followed duriong the procedural sedation, for an average time of thirty minutes after the first injection
Measured: vomiting is assessed after procedural sedation for each patient (30 minutes)
Recovery time
Patient will be followed duriong the procedural sedation, for an average time of thirty minutes after the first injection
Measured: Recovery time is assessed after procedural sedation for each patient (30 minutes)
Proportion of procedural failures
Patient will be followed duriong the procedural sedation, for an average time of thirty minutes after the first injection
Measured: Procedural failure is noted for each patient if it's happened (30 minutes)
Level of patient's satisfaction
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
Measured: after procedural sedation, patient's satisfaction is recorded (30 minutes)
Level of care giver's satisfaction
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
Measured: after procedural sedation, care giver's satisfaction is recorded (30 minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2012 (estimated)
- Study startApr 2012
- Primary completionJan 2016
- Study completionJan 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for FractureStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NiceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 150 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Fabien LEMOEL, MD, Principal investigator, CHU de Nice, FRANCEJacques LEVRAUT, PD, MD, Study director, CHU de Nice, FRANCE
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01544725
- Sponsor's protocol ID
- 11-PP-16
- Status last verified
- Mar 2026
- First submitted
- 6 Feb 2012
- Last updated
- 31 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Lemoel F, Contenti J, Giolito D, Boiffier M, Rapp J, Istria J, Fournier M, Ageron FX, Levraut J. Adverse Events With Ketamine Versus Ketofol for Procedural Sedation on Adults: A Double-blind, Randomized Controlled Trial. Acad Emerg Med. 2017 Dec;24(12):1441-1449. doi: 10.1111/acem.13226. Epub 2017 Jul 14.
PubMed 28493642
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults : a Blinded, Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT01544725
- Acronym / sponsor ID
- 11-PP-16
- Conditions
- Fracture, Dislocation
- Keywords
- Procedural sedation, Ketamine-propofol, Ketamine
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 150 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de NiceUniversity, hospital or other
- Study start
- Apr 2012
- Primary completion
- Jan 2016 (actual)
- Study completion
- Jan 2016 (actual)
- First posted
- 6 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Using Ketamine for procedural sedation in adults is often uncomfortable for emergency physicians because of the significant proportion of patients experimenting recovery agitation. The investigators believe that combining propofol to ketamine, the proportion of recovery agitation will be significantly lowered.
The objectives of this double-blinded, randomized controlled trial are to compare the proportion of recovery agitation in adults receiving procedural sedation with ketamine-propofol versus ketamine alone, and to compare the proportion of other classical procedural sedation side-effects and parameters such as respiratory depression, hypotension, sedation duration, time of recovery, procedural failures, and levels of satisfaction.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ketamine-propofol | Experimental | Drug: Procedural sedation with ketamine-propofol combination |
| Ketamine alone | Active comparator | Drug: Procedural sedation with ketamine alone |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- 18 years and older
- indication of procedural sedation
Key exclusion criteria (5 listed)
- allergy to propofol or ketamine
- alcohol or drug intoxication
- altered mental status
- ASA physical status score > 2
- hemodynamic unstability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Procedural sedation with ketamine-propofol combinationK= Kétamine P= Propofol RSS= Ramsay Sedation Score At t0: 0.5 mg/kg of K (0.1 ml/kg of 5 mg/ml K) followed by 0.5 mg/k of P (0.1 ml/kg of 5 mg/ml P). At t0 + 4 min, if needed to obtain an optimal sedation (RSS of 4 or 5): 0.25 mg/kg of K (0.05 ml/kg of 5 mg/ml K) followed by 0.25 mg/kg of P (0.05 ml/kg of 5 mg/ml P). At t0 + 8 min, if needed to obtain an optimal sedation (RSS of 4 or 5): 0.25 mg/kg of K (0.05 ml/kg of 5 mg/ml K) followed by 0.25 mg/kg of P (0.05 ml/kg of 5 mg/ml P). At t0 + 12 min, if maximal doses have been reached (1 mg/kg of K + 1 mg/kg of P) but the optimal sedation has not been obtained, the procedural sedation will be recorded as a failure in the analysis, and the patient will receive another procedural sedation product (at the discretion of the caregiver). | Drug | Ketamine-propofol |
| Procedural sedation with ketamine aloneK= Ketamine I= Intralipid placebo At t0: 1 mg/kg of K (0.1 ml/kg of 10 mg/ml K), followed by 0.1 ml/kg of I (physical placebo of propofol in the other arm). At t0 + 4 min, if needed to obtain an optimal sedation (Ramsay Sedation Score of 4 or 5): 0.5 mg/kg of K (0.05 ml/kg of 10 mg/ml K), followed by 0.05 ml/kg of I. At t0 + 8 min, if needed to obtain an optimal sedation (Ramsay Sedation Score of 4 or 5): 0.5 mg/kg of K (0.05 ml/kg of 10 mg/ml K), followed by 0.05 ml/kg of I. At t0 + 12 min, if maximal doses have been used (2 mg/kg of K) but the optimal sedation has not been obtained, the procedural sedation will be recorded as a failure in the analysis, and the patient will receive another procedural sedation product (at the discretion of the caregiver). | Drug | Ketamine alone |
Primary outcome
Proportion of recovery agitation
Time frame: Recovery agitation is noted after procedural sedation for each patient (30 minutes)
Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection
8 secondary outcomes
Time from first injection to optimal sedation
Time frame: Patient will be followed during the procedural sedation, for an average time of thirty minutes after the first injection (30 minutes)
Proportion of respiratory depression
Time frame: respiratory depression is assessed during procedural sedation for each patient (30 minutes)
Proportion of arterial hypotension
Time frame: Hypotension is assessed during procedural sedation for each patient (30 minutes)
Proportion of vomiting
Time frame: vomiting is assessed after procedural sedation for each patient (30 minutes)
Recovery time
Time frame: Recovery time is assessed after procedural sedation for each patient (30 minutes)
Proportion of procedural failures
Time frame: Procedural failure is noted for each patient if it's happened (30 minutes)
Level of patient's satisfaction
Time frame: after procedural sedation, patient's satisfaction is recorded (30 minutes)
Level of care giver's satisfaction
Time frame: after procedural sedation, care giver's satisfaction is recorded (30 minutes)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2026.
- Results publication: PubMed 28493642Lemoel F, Contenti J, Giolito D, Boiffier M, Rapp J, Istria J, Fournier M, Ageron FX, Levraut J. Adverse Events With Ketamine Versus Ketofol for Procedural Sedation on Adults: A Double-blind, Randomized Controlled Trial. Acad Emerg Med. 2017 Dec;24(12):1441-1449. doi: 10.1111/acem.13226. Epub 2017 Jul 14.
Related trials for Fracture
Not yet recruiting
Biodegradable Magnesium Screws for Unstable Ankle Fracture Surgery
Ankle Fractures, Syndesmotic Injury
Active, not recruitingObservational study
The Developmental Origins of Suicide Mortality
Suicide Mortality
RecruitingObservational study
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
Proximal Humeral Fracture, Reverse Total Shoulder Arthroplasty
Recruiting
No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
Distal Radius Fracture, Casting
RecruitingObservational study
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Vertebra Compression Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fabien LEMOEL, MD principal investigator
CHU de Nice, FRANCE
Jacques LEVRAUT, PD, MD study director
CHU de Nice, FRANCE
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Procedural sedation with ketamine-propofol combination and Procedural sedation with ketamine alone in people with Fracture and Dislocation, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of recovery agitation (time frame: Recovery agitation is noted after procedural sedation for each patient (30 minutes)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01544725, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026; AzTrials last refreshed its copy on 8 Nov 2026.